CHENGDU, China, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Maase Inc. (NASDAQ: MAAS) (“MAAS” or the “Company”) today announced the successful completion of its strategic acquisition of 100% equity interests in Carve Group Ltd (the “Target Company” or the “Carve Group”). The transaction, previously disclosed in the Company’s Form 6-K filed on July 29, 2025, was formally consummated on August 27, 2025. Pursuant to the transaction agreement dated July 28, 2025, MAAS has acquired all equity interests in the Target Compa ...

Group 1 - The 2025 China Private Enterprise Investment and Financing Fair will be held in Tianjin in late September, focusing on high-quality development of the private economy with the theme "Promoting High-Quality Development of Private Economy - New Quality Improvement, Co-Creating the Future" [1] - The fair will feature a series of activities including one main event, four brand activities, and multiple supporting activities, aimed at facilitating project negotiations and financing connections among private enterprises, state-owned enterprises, and financial institutions [1] - The fair has been held 16 times since 2007, with nearly 30,000 enterprises and institutions participating and a total financing scale of approximately 385 billion yuan, serving as an effective platform for promoting the development of the private economy and industrial upgrading [3] Group 2 - The first roadshow event for the fair, focusing on the biopharmaceutical sector, showcased 10 quality project companies, including Beijing Anlong Biopharmaceutical Co., Ltd. and Tianjin Tianshili Smart Traditional Chinese Medicine Technology Co., Ltd., highlighting the latest innovations and development potential in the field [3] - Notable investment institutions and financial organizations participated in the roadshow, including Haihe Industrial Fund and China Bank Tianjin Branch, facilitating precise connections between projects and capital [3] - The roadshow aimed to create a high-quality matching environment and will continue to hold a series of roadshows across different industrial sectors to support the high-quality development of private enterprises [4]

沪指跌0.36%，深成指跌0.53%，创业板指跌0.66%。AI产业链普遍回调，CPO、AI应用概念跌幅居前， PCB、华鲲振宇概念集体下挫；贵金属跟随期市回暖，中药股造好。 ...

按照计划，各试点地区可结合当地实际选择试点医院先行先试，在总结经验的基础上，不断优化政 策措施，逐步扩大保障范围和适应病症。其中，南阳8月1日起将在全省率先实施中医适宜技术门诊治疗 纳入医保支付，当地8家中医院作为首批试点单位开展此项服务。 据介绍，新政不仅有利于在日常诊疗中积极应用中医适宜技术，而且还解决了慢性病中医诊疗服务 在门诊保障不足的问题，同时也为中医药在治未病、重大疾病治疗、疾病康复等方面的推广发挥了重要 作用。 为充分发挥中医药在重大疾病治疗以及康复治疗中的重要作用，河南省试点将中医适宜技术纳入医 保支付范围，郑州、南阳、驻马店、漯河、三门峡5个城市纳入省级试点。这是记者昨日从河南省医疗 保障局获得的信息。 为深入推动中医药融入三医协同发展，我省不断健全鼓励中医药服务供给和使用的政策机制，计划 将具有确切疗效且体现中医特色的适宜技术纳入医保门诊支付范围，更好满足参保群众中医药服务需 求。为此，省医保局、省卫生健康委联合出台新政，确定郑州、南阳、驻马店、漯河、三门峡5个城市 作为省级试点，将灸法、拔罐、推拿等7大类56项中医适宜技术全部纳入医保门诊支付范围，首批遴选 颈椎病等20种中医适宜技术适应 ...

Core Insights - The report from Meituan Health highlights that users born in the 1990s and 1995s account for over half of the traditional Chinese medicine (TCM) wellness consumption, indicating a shift towards younger demographics in this sector [1][3] - A new social trend has emerged among professionals, where groups of friends visit TCM clinics after work for relaxation and therapy, showcasing a growing interest in TCM wellness practices [1] - The sales of Sanfu TCM patches have surged by 176% ahead of the summer solstice, with significant regional differences, particularly in southern cities like Guangzhou, Shenzhen, and Foshan leading the sales rankings [1] User Demographics and Preferences - Among users seeking TCM therapies, those born in the 1990s represent over 45% of the total clientele, emphasizing the dominance of younger consumers in this market [1] - Popular services among users include shoulder and neck massage, TCM massage, and pediatric massage, reflecting a preference for hands-on therapeutic experiences [1] Sales Trends and Market Dynamics - The Sanfu patch sales are characterized by a dual consumption trend: home delivery users prefer established brands like Nanjing Tongrentang and Beijing Tongrentang, while in-store group buyers favor comprehensive TCM hospitals, indicating a trust shift towards professional medical institutions [1] - The overall transaction volume for Meituan's TCM services has increased by 139% year-on-year, highlighting the growing integration of online and offline TCM services [3] Strategic Initiatives - In response to the rising demand from younger consumers for convenient and professional TCM services, Meituan plans to launch a series of activities during the Sanfu wellness season, covering various wellness scenarios [3] - The company aims to provide a one-stop service that combines online ordering with in-store experiences, making traditional TCM wellness more accessible and socially engaging [3]

Group 1 - The core point of the article is that Tongrentang Medical Investment Co., Ltd. has submitted its third listing application to the Hong Kong Stock Exchange, with CITIC Securities as the sole sponsor. If successful, it will become the fourth listed platform under the Tongrentang Group [1] Group 2 - Tongrentang Medical is a traditional Chinese medicine healthcare group providing comprehensive medical services to individual clients and standardized management services to institutional clients, along with various pharmaceutical and other products [5] - As of the latest feasible date, Tongrentang Medical has established a tiered medical service network, including 12 self-owned offline medical institutions and one internet hospital, as well as 10 offline managed medical institutions [5] - By 2024, Tongrentang Medical is the largest non-public traditional Chinese medicine hospital group in China, holding a market share of 1.7% in terms of total outpatient and inpatient visits [5] - In terms of total medical service revenue for 2024, Tongrentang Medical accounts for 46.5% of the total market size of the traditional Chinese medicine healthcare service industry in China [5] - The company's revenue primarily comes from medical services, management services, and sales of health products and other products, with medical services generating approximately 995 million yuan, management services about 9.6 million yuan, and health product sales around 138 million yuan for the fiscal year 2023 [5] - The company's revenue for the fiscal years 2022, 2023, and 2024 was approximately 911 million yuan, 1.153 billion yuan, and 1.175 billion yuan respectively, with net profits of -9.233 million yuan, 42.634 million yuan, and 46.197 million yuan during the same periods [5]

Core Insights - The Qingdao Traditional Chinese Medicine (TCM) Inheritance and Innovation Base project has successfully passed its completion inspection, showcasing a modern park dedicated to the mission of TCM inheritance and innovation [1] Group 1: Project Overview - The first phase of the Qingdao TCM Inheritance and Innovation Base project covers approximately 150 acres with a total construction area of about 150,000 square meters, consisting of 14 individual buildings that include various functional areas such as laboratories, research incubation buildings, and wellness centers [3] - The project is divided into two main sections: the west area focuses on research and incubation with a design inspired by Tai Chi and traditional Chinese elements, while the east area emphasizes medical and wellness services, incorporating classical garden design and traditional courtyard structures [3] Group 2: Facilities and Features - The experimental building A is spacious and well-lit, featuring areas for the cultivation and exhibition of traditional Chinese medicinal plants, as well as pilot workshops and animal laboratories for innovative experiments [5] - The research incubation building spans approximately 7,700 square meters and includes meeting rooms, offices, and a 400-person auditorium, while the research support building offers dining, conference, and accommodation facilities with a total area of about 20,000 square meters [7] - The wellness building provides a comfortable living environment with 116 wellness apartments and 162 beds for elderly care, along with transitional medical service areas for patients [7] Group 3: Collaboration and Future Plans - The project will collaborate with Shandong University of Traditional Chinese Medicine to establish a hospital that leverages expert resources to provide TCM diagnosis and treatment services for complex diseases, as well as preventive care and wellness services [9] - As a key construction project in Qingdao High-tech Zone, the TCM base aims to become a highland for marine TCM research and an innovation hub, integrating technology innovation, talent cultivation, and industry incubation to enhance TCM and wellness services for the local community [9]

Group 1 - The core viewpoint emphasizes the rapid development of technology innovation in Hong Kong and Macau, driven by strong governmental support and collaboration within the Guangdong-Hong Kong-Macau Greater Bay Area [1][2][3] - Hong Kong's technology innovation is supported by its robust research capabilities, with five universities ranked among the world's top 100 and over 40 academicians from national academies, creating a favorable environment for tech enterprises [2] - Macau is entering a new phase of technology innovation, with plans to invest at least 5 billion Macanese Patacas in R&D over the next five years, marking the highest investment in its history [2] Group 2 - The collaboration within the Greater Bay Area is enhancing the flow of capital, technology, talent, and information, providing broader opportunities for technology innovation in Hong Kong and Macau [3] - Platforms like the Qianhai Shenzhen-Hong Kong Youth DreamWorks and Hengqin Macau Youth Entrepreneurship Valley are becoming popular among young people in Hong Kong and Macau, facilitating their entrepreneurial ventures [3] - The article highlights the potential for Hong Kong and Macau to leverage their unique advantages and actively integrate into the Greater Bay Area's technology innovation ecosystem to achieve high-quality development [3]

Core Insights - The introduction of the "Qizhi" AI model by Guang'anmen Hospital represents a significant upgrade in the application of AI within traditional Chinese medicine (TCM), aiming to enhance diagnostic efficiency and patient care [1][2] - The model integrates various medical scenarios and TCM-specific data, allowing for multi-modal analysis and improving the overall diagnostic capabilities of TCM practitioners [1][2] - The AI model is expected to standardize and elevate the diagnostic skills of TCM practitioners across hospitals, potentially leading to a transformative impact on the industry [2][9] Group 1: AI Integration in TCM - Guang'anmen Hospital's "Qizhi" model is the first localized deployment of an integrated AI service in TCM, covering outpatient, inpatient, and surgical scenarios [1] - The model utilizes patient data from over 10,000 daily consultations to continuously learn and improve its diagnostic capabilities [1][11] - The AI aims to assist rather than replace TCM practitioners, allowing them to focus on service quality and patient experience [1][2] Group 2: Industry Trends and Challenges - The TCM industry is experiencing a surge in AI model development, with over 10 publicly released models and at least 50 in development by various institutions [2][5] - The need for modernization, internationalization, and standardization in TCM is critical for its survival and growth, with AI models seen as a key driver for this transformation [6][10] - Recent changes in healthcare payment policies are pressuring TCM practitioners to enhance their service capabilities, further driving the adoption of AI technologies [4][10] Group 3: Market Potential - The TCM health industry in China reached a scale of 1.28 trillion yuan in 2022, with projections to exceed 1.8 trillion yuan by 2025, indicating a substantial market opportunity for AI applications [14] - The demand for TCM services has been growing rapidly, with a reported increase of over 25% in TCM outpatient services in 2023 [13] - The integration of AI in TCM is expected to create a market space worth billions, highlighting the financial potential of AI-driven solutions in the healthcare sector [14] Group 4: Data and Research - Guang'anmen Hospital has accumulated a vast amount of clinical data, including 4.07 million case records and 14 million clinical knowledge entries, making it one of the most data-rich TCM institutions in China [11][12] - The challenge of standardizing TCM practices remains, as the field is characterized by subjective interpretations and a lack of unified treatment protocols [10][24] - The development of AI models in TCM is hindered by the need for high-quality, structured data, which is currently lacking in the industry [10][20]